封面
市场调查报告书
商品编码
1671907

迷走神经刺激设备市场:按产品类型、按应用、按材料类型、按最终用户、按地区

Vagus Nerve Stimulators Market, By Product Type, By Application, By Material Type , By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 162 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球迷迷走神经刺激设备市场规模估计为 6.674 亿美元,预计到 2032 年将达到 12.931 亿美元,2025 年至 2032 年的复合年增长率为 9.9%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 6.674亿美元
效能资料 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 9.90% 2032 年价值预测 12.931亿美元
数字。 2025 年迷走神经刺激设备各地区市场占有率(%)
迷走神经刺激器市场 - IMG1

迷走神经是最长的脑神经,与心臟等身体的多个器官相互作用。迷走神经刺激 (VNS) 涉及使用称为迷走神经刺激设备的植入式医疗设备向迷走神经传送电脉衝。这种治疗方法是基于刺激迷走神经可以控制异常大脑活动并抑制癫痫发作的原理。迷走神经刺激设备可作为辅助性治疗,减少药物无法充分控制的癫痫患者的发作频率和严重程度。人们也正在探索VNS在治疗其他神经和精神疾病(如忧郁症、阿兹海默症和偏头痛)方面的治疗潜力。

市场动态:

全球迷迷走神经刺激设备市场的发展受到癫痫和其他神经系统疾病盛行率上升、人们对迷走神经刺激器疗法的认识和接受度不断提高以及有利的报销政策的推动。然而,迷走神经刺激设备和手术的高成本以及与迷走神经刺激相关的副作用和併发症是市场成长的主要限制因素。功能增强的创新刺激器的开发和 VNS 治疗应用的扩展为高效渲染提供了机会。相关人员正在投资研究试验,以评估 VNS 在抗治疗性忧郁症、类风湿性关节炎和心臟衰竭等疾病方面的有效性。

本研究的主要特点

  • 本研究报告对全迷走神经刺激设备市场进行了详细分析,并提供了预测期(2025-2032)的市场规模和年复合成长率(CAGR%),以 2024 年为基准年。
  • 它揭示了不同领域的潜在收益成长机会,并解释了该市场的引人注目的投资提案矩阵。
  • 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 报告根据公司亮点、产品系列、关键亮点、财务表现和策略等参数,概述了全迷走神经刺激设备市场的主要企业。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球迷迷走神经刺激设备市场报告迎合了该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过分析全迷走神经刺激设备市场所使用的各种策略矩阵来简化决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 管道分析
  • PEST分析
  • 监管情景
  • 市场趋势
  • 主要亮点
  • 退款情形
  • 合併和收购

4. 全迷走神经刺激设备市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 经济影响
  • 对临床试验和药物开发的影响
  • 政府倡议

5. 2020 年至 2032 年全迷走神经刺激设备市场(依产品类型)

  • 嵌入式装置
  • 外部设备

6. 2020 年至 2032 年全迷走神经刺激设备市场(依应用)

  • 癫痫
  • 忧郁症和焦虑
  • 偏头痛
  • 其他的

7. 2020 年至 2032 年全迷走神经刺激设备市场(依材料类型)

  • 陶瓷製品
  • 金属
  • 聚合物

8. 全迷走神经刺激设备市场,依最终用户划分,2020 年至 2032 年

  • 医院
  • 专科门诊
  • 门诊手术中心
  • 其他的

9. 2020 年至 2032 年全迷走神经刺激设备市场(按地区)

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第十章 竞争格局

  • 热图分析
  • 市场占有率分析
    • LivaNova PLC
    • electroCore, Inc.
    • SetPoint Medical Corporation
    • Beijing PINS Medical Co., Ltd.
    • Parasym Ltd.
    • Nervana, LLC
    • tVNS Technologies GmbH
    • BioControl Medical
    • NeurAxis, Inc.
    • Soterix Medical Inc.
    • MicroTransponder Inc.
    • Boston Scientific Corporation
    • Cyberonics, Inc.
    • EnteroMedics Inc.
    • ReShape Lifesciences Inc.
    • Cerbomed GmbH

第 11 章 分析师观点

  • 命运之轮
  • 分析师观点
  • 一致的机会地图

第 12 章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI2514

Global Vagus Nerve Stimulators Market is estimated to be valued at USD 667.4 Mn in 2025 and is expected to reach USD 1,293.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 667.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.90% 2032 Value Projection: USD 1,293.1 Mn
Figure. Vagus Nerve Stimulators Market Share (%), By Region 2025
Vagus Nerve Stimulators Market - IMG1

The vagus nerve is the longest cranial nerve that interacts with several organs of the body including the heart. Vagus nerve stimulation or VNS involves delivering electrical pulses to the vagus nerve using an implantable medical device called a vagus nerve stimulator. This therapy relies on the principle that stimulating the vagus nerve can help regulate abnormal brain activity and seizure control. Vagus nerve stimulators are used as an adjunctive therapy for reducing the frequency and severity of seizures in patients with epilepsy whose conditions are not fully controlled by medications. The therapeutic potential of VNS is being explored for treating other neurological and psychiatric disorders such as depression, Alzheimer's disease, and migraine too.

Market Dynamics:

The global vagus nerve stimulators market is driven by the rising prevalence of epilepsy and other neurological disorders, growing awareness and acceptance of VNS therapy, and favorable reimbursement policies. However, high costs associated with VNS devices and surgeries coupled with adverse effects and complications associated with stimulation of the vagus nerve act as key restraints for the market growth. Development of innovative stimulation devices with improved features and expanding therapeutic applications of VNS present high-impact rendering opportunities. Stakeholders are investing in research trials to evaluate the efficacy of VNS in conditions such as treatment-resistant depression, rheumatoid arthritis, and heart failure.

Key Features of the Study:

  • This report provides an in-depth analysis of the global vagus nerve stimulators market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global vagus nerve stimulators market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include LivaNova PLC, electroCore Inc., SetPoint Medical Corporation, Beijing PINS Medical Co. Ltd., Parasym Ltd., Nervana LLC, tVNS Technologies GmbH, BioControl Medical, NeurAxis Inc., Soterix Medical Inc., MicroTransponder Inc., Boston Scientific Corporation, Cyberonics Inc., EnteroMedics Inc., ReShape Lifesciences Inc., and Cerbomed GmbH.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global vagus nerve stimulators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vagus nerve stimulators market.

Market Segmentation

  • Product Type:
    • Implantable Devices
    • External Devices
  • Application:
    • Epilepsy
    • Depression & Anxiety
    • Migraine
    • Others
  • Material Type:
    • Ceramics
    • Metallics
    • Polymerics
  • End User:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • LivaNova PLC
    • electroCore Inc.
    • SetPoint Medical Corporation
    • Beijing PINS Medical Co. Ltd.
    • Parasym Ltd.
    • Nervana LLC
    • tVNS Technologies GmbH
    • BioControl Medical
    • NeurAxis Inc.
    • Soterix Medical Inc.
    • MicroTransponder Inc.
    • Boston Scientific Corporation
    • Cyberonics Inc.
    • EnteroMedics Inc.
    • ReShape Lifesciences Inc.
    • Cerbomed GmbH

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By Material Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • PEST Analysis
  • Regulatory Scenario
  • Market Trends
  • Key Highlights
  • Reimbursement Scenario
  • Mergers & Acquisitions

4. Global Vagus Nerve Stimulators Market - Impact of Coronavirus (COVID-19) Pandemic

  • Economic Impact
  • Impact on Clinical Trials and Drug Development
  • Government Initiatives

5. Global Vagus Nerve Stimulators Market, By Product Type, 2020 - 2032, (USD MN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Implantable Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • External Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)

6. Global Vagus Nerve Stimulators Market, By Application, 2020 - 2032, (USD MN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Epilepsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Depression & Anxiety
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Migraine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)

7. Global Vagus Nerve Stimulators Market, By Material Type, 2020 - 2032, (USD MN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Ceramics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Metallics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Polymerics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)

8. Global Vagus Nerve Stimulators Market, By End User, 2020 - 2032, (USD MN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)

9. Global Vagus Nerve Stimulators Market, By Region, 2020 - 2032, (USD MN)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
  • North America
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Material Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD MN)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Material Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD MN)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Material Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD MN)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Material Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD MN)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Material Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD MN)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Material Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (USD MN)
      • South Africa
      • Central Africa
      • North Africa

10. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • LivaNova PLC
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • electroCore, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • SetPoint Medical Corporation
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Beijing PINS Medical Co., Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Parasym Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Nervana, LLC
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • tVNS Technologies GmbH
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • BioControl Medical
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • NeurAxis, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Soterix Medical Inc.
    • MicroTransponder Inc.
    • Boston Scientific Corporation
    • Cyberonics, Inc.
    • EnteroMedics Inc.
    • ReShape Lifesciences Inc.
    • Cerbomed GmbH

11. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact